EA201290262A1 - Способы получения ингибиторов активирующего 5-липоксигеназу белка и их промежуточных продуктов - Google Patents
Способы получения ингибиторов активирующего 5-липоксигеназу белка и их промежуточных продуктовInfo
- Publication number
- EA201290262A1 EA201290262A1 EA201290262A EA201290262A EA201290262A1 EA 201290262 A1 EA201290262 A1 EA 201290262A1 EA 201290262 A EA201290262 A EA 201290262A EA 201290262 A EA201290262 A EA 201290262A EA 201290262 A1 EA201290262 A1 EA 201290262A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- activating
- intermediate products
- inhibitors
- lipoxygenase protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к способам, применимым для получения ингибиторов активирующего 5-липоксигеназу белка (FLAP) и их промежуточных продуктов. В частности, предусмотрены способы получения 3-[3-(трет-бутилсульфанил)-1-[4-(6-этоксипиридин-3-ил)бензил]-5-(5-метилпиридин-2-илметокси)-1Н-индол-2-ил]-2,2-диметилпропионовой кислоты, безводного полиморфа формы С 3-[3-(трет-бутилсульфанил)-1-[4-(6-этоксипиридин-3-ил)бензил]-5-(5-метилпиридин-2-илметокси)-1Н-индол-2-ил]-2,2-диметилпропионата натрия, и промежуточных продуктов, применимых в упомянутых способах.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25747909P | 2009-11-03 | 2009-11-03 | |
US26045309P | 2009-11-12 | 2009-11-12 | |
US36617810P | 2010-07-21 | 2010-07-21 | |
PCT/EP2010/066577 WO2011054783A2 (en) | 2009-11-03 | 2010-11-02 | Novel processes |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201290262A1 true EA201290262A1 (ru) | 2013-01-30 |
Family
ID=43970448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290262A EA201290262A1 (ru) | 2009-11-03 | 2010-11-02 | Способы получения ингибиторов активирующего 5-липоксигеназу белка и их промежуточных продуктов |
Country Status (13)
Country | Link |
---|---|
US (1) | US20120220779A1 (ru) |
EP (1) | EP2496571A2 (ru) |
JP (1) | JP2013510115A (ru) |
KR (1) | KR20130028701A (ru) |
CN (1) | CN102822166A (ru) |
AU (1) | AU2010314177B2 (ru) |
BR (1) | BR112012010525A2 (ru) |
CA (1) | CA2779786A1 (ru) |
EA (1) | EA201290262A1 (ru) |
IL (1) | IL219316A0 (ru) |
MX (1) | MX2012005153A (ru) |
WO (1) | WO2011054783A2 (ru) |
ZA (1) | ZA201202840B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200920369A (en) * | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
US20110160249A1 (en) * | 2008-05-23 | 2011-06-30 | Schaab Kevin Murray | 5-lipoxygenase-activating protein inhibitor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5274096A (en) | 1992-03-17 | 1993-12-28 | Merck & Co., Inc. | Hydrazine synthesis |
US5288743A (en) | 1992-11-20 | 1994-02-22 | Abbott Laboratories | Indole carboxylate derivatives which inhibit leukotriene biosynthesis |
UA72748C2 (en) * | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
US7977359B2 (en) * | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
CN101331117B (zh) * | 2005-11-04 | 2012-09-05 | 阿米拉制药公司 | 5-脂氧合酶活化蛋白(flap)抑制剂 |
GB2431927B (en) * | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
US20110160249A1 (en) * | 2008-05-23 | 2011-06-30 | Schaab Kevin Murray | 5-lipoxygenase-activating protein inhibitor |
-
2010
- 2010-11-02 EA EA201290262A patent/EA201290262A1/ru unknown
- 2010-11-02 US US13/503,867 patent/US20120220779A1/en not_active Abandoned
- 2010-11-02 CA CA2779786A patent/CA2779786A1/en not_active Abandoned
- 2010-11-02 AU AU2010314177A patent/AU2010314177B2/en not_active Ceased
- 2010-11-02 JP JP2012537359A patent/JP2013510115A/ja active Pending
- 2010-11-02 EP EP10771473A patent/EP2496571A2/en not_active Withdrawn
- 2010-11-02 MX MX2012005153A patent/MX2012005153A/es not_active Application Discontinuation
- 2010-11-02 BR BR112012010525A patent/BR112012010525A2/pt not_active IP Right Cessation
- 2010-11-02 WO PCT/EP2010/066577 patent/WO2011054783A2/en active Application Filing
- 2010-11-02 KR KR1020127011406A patent/KR20130028701A/ko not_active Application Discontinuation
- 2010-11-02 CN CN2010800604675A patent/CN102822166A/zh active Pending
-
2012
- 2012-04-17 ZA ZA2012/02840A patent/ZA201202840B/en unknown
- 2012-04-19 IL IL219316A patent/IL219316A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20130028701A (ko) | 2013-03-19 |
MX2012005153A (es) | 2012-10-09 |
EP2496571A2 (en) | 2012-09-12 |
BR112012010525A2 (pt) | 2015-09-29 |
IL219316A0 (en) | 2012-06-28 |
CA2779786A1 (en) | 2011-05-12 |
ZA201202840B (en) | 2013-09-25 |
AU2010314177B2 (en) | 2014-05-08 |
JP2013510115A (ja) | 2013-03-21 |
WO2011054783A3 (en) | 2011-07-07 |
CN102822166A (zh) | 2012-12-12 |
US20120220779A1 (en) | 2012-08-30 |
AU2010314177A1 (en) | 2012-05-10 |
WO2011054783A2 (en) | 2011-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600174B (it) | Forme solide di acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]diossol-5-il)ciclopropancarbossammido)-3-metilpiridin-2-il)benzoico | |
MY170036A (en) | Process for the regioselective preparation of 1-alky1-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
MX347257B (es) | Solido de gamma-carbolinas fusionadas con heterociclos substituidos. | |
NO20076067L (no) | Metoder for syntese av substituerte 3-cyanokinoliner og mellomprodukter av denne | |
UA111725C2 (uk) | Кристалічний (r)-(e)-2-(4-(2-(5-(1-(3,5-дихлорпіридин-4-іл)етоксі)-1h-індазол-3-іл)вініл)-1h-піразол-1-іл)етанол | |
EA201100517A1 (ru) | Способ получения дабигатрана и его промежуточные соединения | |
EA200702614A1 (ru) | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот | |
CR20110554A (es) | Formulaciones líquidas de sales de 1-[2-(2,4-dimetilfenilsulfanil)-fenil-piperazina | |
ATE486601T1 (de) | Verwendung von 3- (4-amino-1-oxo-1,3-dihydro- isoindol-2-yl)-piperidin--2,6-dion zur behandlung von mantelzelllymphomen | |
DE602006019595D1 (de) | Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors | |
IL220211A (en) | Process for Preparation of Acid History 1 - (Alkyl / Phenyl / Pyrid-2-Il) -5-Carboxylic Pyrazole and Intermediates Obtained in This Process | |
EA201000486A1 (ru) | Ингибитор белка, активирующего 5-липоксигеназу (flap) | |
PL2379093T3 (pl) | Kompozycje do leczenia choroby refluksowej przełyku (GERD) | |
MX2010008583A (es) | Novedosos formas cristalinas de acido 4-[4-(2-adamantilcarbamoil)- 5-ter-butil-pirazol-1-il]benzoico. | |
DK2285765T3 (da) | Fremgangsmåde til fremstilling af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre | |
EA201291346A1 (ru) | Полиморфы osi-906 | |
EA201071221A1 (ru) | Гетероциклические соединения | |
WO2007081995A3 (en) | Urotensin ii receptor antagonists | |
EA201200820A1 (ru) | Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов | |
EA201001870A1 (ru) | Новые кристаллические формы рабепразола натрия | |
UA107336C2 (ru) | Синтез и солевые формы (r)-5-((e)-2-пирролидин-3-илвинил) пиримидина | |
MX367327B (es) | Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos. | |
DK2462118T3 (da) | Fremgangsmåde til fremstilling af 1-benzyl-3-hydroxymethyl-1H-indazol og dets derivater og nødvendige magnesiummellemprodukter | |
EA201290262A1 (ru) | Способы получения ингибиторов активирующего 5-липоксигеназу белка и их промежуточных продуктов | |
HK1175783A1 (en) | Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors (/)-()-1-(/)-()-1- p75 |